Table 7 Comparison of unadjusted ten-year oncologic survival outcomes between men with a detectable post-salvage treatment PSA for 3348 patients who underwent radical prostatectomy at University of California, San Francisco.
From: The natural history of a delayed detectable PSA after radical prostatectomy
Outcome | Tertiary treatment | No tertiary treatment | |||
|---|---|---|---|---|---|
Lifetable estimate | Still at risk at 10 yrs | Lifetable estimate | Still at risk at 10 yrs | p-value | |
% at 10 years | N | % at 10 years | N | ||
Metastasis-free survival | 54 | 10 | 91 | 57 | <0.01 |
Prostate cancer mortality | 23 | 14 | 0 | 60 | <0.01 |
All-cause mortality | 23 | 14 | 3 | 60 | <0.01 |
